Daniel Alexander QC and James Whyte acted for J&J group company, Janssen, in defence of a patent in the field of chiral chemistry relating to beta-blocking agents for hypertension. The judgment of Floyd J, from the hearing in May 2008, addressed the scope of application of the Mobil approach to second medical uses, and obviousness where a research programme was required.
+44(0)20 7405 4321
clerks@8newsquare.co.uk